Global 3D Bioprinting Market Insights Forecasts to 2030
- The 3D Bioprinting Market Size was valued at USD 2.1 billion in 2021.
- The Worldwide Market Share is growing at a CAGR of 20.4% from 2022 to 2030
- The Global 3D Bioprinting Market Size is expected to reach USD 5.5 billion by 2030
- North America is expected to grow the fastest during the forecast period
Get more details on this report -
The Global 3D Bioprinting Market Size is expected to reach USD 5.5 billion by 2030, at a CAGR of 20.4% during the forecast period 2022 to 2030. The lack of organ donors and increasing number of aging population having chronic respiratory ailments are driving the market growth. Apart from this, the increasing research and development investment, advancement in technology and rising cases of chronic diseases are boosting overall growth of the market over the forecast period.
3D Bioprinting is an additive form of manufacturing which uses 3D printing that helps in fabricating the biomedical parts which imitate natural tissue features. In fact, 3D Bioprinting make uses of the layer by layer method with an aim to deposit materials known as bioinks which helps in creating tissue based structures which are widely used in tissue and medical engineering fields. The 3D Bioprinting includes bioprinting, pre-bioprinting, and post-bioprinting. 3D Bioprinting are mainly used to develop organ as well as tissue constructs which are used for the research and development of drugs, development of medical implants, and scaffolds. Apart from this, 3D Bioprinting has started to use the printing scaffolds which are utilized in regenerating ligaments and joints. It contributes to significant advances in the tissue engineering fields by allowing the research to be done the biomaterials or innovative materials.
This research report categorizes the market for 3D Bioprinting market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the 3D Bioprinting market. Recent market developments and competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the 3D Bioprinting market.
The global 3D Bioprinting Market is anticipated to witness a remarkable growth over the forecast period owing to the rising use of the 3D bioprinting in the field of biotechnology, pharmaceutical, and healthcare. Furthermore, the increasing use of 3D printing in cosmetic surgeries as well as inventions in 3D bioprinting is expected to drive the global 3D Bioprinting Market growth in the predicted timeframe. Apart from this, the increasing private and public funding to boost bioprinting research activities has driven the market.
The technological advancement in the field of 3D bioprinting have occurred for several medical applications along with cancer therapeutics, tissue development, liver modeling, and bone and cartilage development is driving the growth of the 3D bioprinting market over the forecast period. Not only this but also various latest development trends which are taking place in 3d bioprinting market. 3D bioprinting plays a significant role in clinical trial applications and drug testing that are anticipated to reduce the requirement of animal trials.
Global 3D Bioprinting Market Report Coverage
|Market Size in 2021:
|USD 2.1 Billion
|Forecast Period 2021-2030 CAGR:
|2030 Value Projection:
|USD 5.5 Billion
|Historical Data for:
|No. of Pages:
|Tables, Charts & Figures:
|By Technology, By Application, By Region, COVID-19 Impact Analysis
|Organovo Holdings, Inc., Envisiontec GmbH, Nano 3D Biosciences, Inc., Regenhu Ltd., Cellink, Vivax Bio, LLC, Cyfuse Biomedical K.K., 3D Bioprinting Solutions, Cellink Global, Advanced Solutions Life Sciences, LLC, Pandorum Technologies pvt., Foldink Life Science Technologies, Precise Bio
|The global 3D Bioprinting Market is anticipated to witness a remarkable growth over the forecast period owing to the rising use of the 3D bioprinting in the field of biotechnology, pharmaceutical, and healthcare.
|Pitfalls & Challenges:
|Due to the increasing number of COVID-19 cases
Get more details on this report -
Certain factors like shortage of skilled labours, increasing production costs, and high developments are affecting the 3D Bioprinting Market growth. Furthermore, the efficient utilization of 3D bioprinting technology requires continuous process monitoring and the process differs in various platforms owing to uncontrolled process variables as well as material differences. All these factors are hindering the overall 3D bioprinting market growth.
- In 2021, the inkjet based segment is dominating the market by holding the largest market share over the forecast period.
On the basis of technology, the global 3D bioprinting market is segmented into Magnetic Levitation, Inkjet-based. Among these, the inkjet based segment is dominating the market by holding the largest market share over the forecast period because it enables the printing of complex living tissues or organs on the culture substrates through bio inks. The increasing adoption of ink jet based printing in the field of medical science is making the contribution on the segmental growth. This work presents in the development trends in inkjet based printing because bio applicable technology, specifically in the drug delivery systems and tissue engineering fields.
- In 2021, the medical segment is witnessing the highest CAGR over the forecast period.
Based on the application, the global 3D bioprinting market is segmented into Medical, Dental, Biosensors, Bioinks. Among these, the medical segment is witnessing the highest CAGR over the forecast period. The rising adoption of medical pills that help in curing chronic health ailments are driving the global 3D bioprinting market growth. Apart from this, the increasing requirement of medications as well as cost effective application of bio drugs through this technology is propelling the segmental growth. Lots of people across the world are using medicinal pills and capsules on a regular basis. Thus, this segment is anticipated to witness a significant growth over the forecast period.
Regional Segment Analysis of the 3D Bioprinting Market
Get more details on this report -
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
Asia Pacific is dominating the market with the largest market share over the forecast period.
Asia Pacific region holds the largest market share and is dominating the market over the forecast period owing the increasing research and development activities, rising need of organ transplants, and initiatives taken by the key market players are boosting the presence in this region. Moreover, the increase mortality rates amidst COVID 19 and lack of organ donors are propelling the market growth in Asia Pacific region.
- November 2019, CELLINK has launched the most advanced 3D bioprinting device known as Bio X6 and Lumen X which produces vascular structures.
The report offers the appropriate analysis of the key organizations/companies involved within the global v market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Market Players
- Organovo Holdings, Inc.
- Envisiontec GmbH
- Nano 3D Biosciences, Inc.
- Cyfuse Biomedical K.K.
- Regenhu Ltd.
- Aspect Biosystems Ltd.
- Vivax Bio, LLC
- Cyfuse Biomedical K.K.
- 3D Bioprinting Solutions
- Cellink Global
- Regemat 3D S.L.
- Bico group ab,
- Collplant Biotechnologies Ltd.
- Advanced Solutions Life Sciences, LLC
- Rokit Healthcare, inc.
- Pandorum Technologies pvt. ltd.
- Foldink Life Science Technologies
- Revotek co., ltd.
- Precise Bio
Key Target Audience
- Market Players
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global 3D Bioprinting market based on the below-mentioned segments:
3D Bioprinting Market, By Technology
- Magnetic Levitation
3D Bioprinting Market, By Application
3D Bioprinting Market, Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Need help to buy this report?